Loading clinical trials...
Loading clinical trials...
This primary objective of this study is to describe the incidence of RSV infection in adult hematopoietic cell transplant recipients OR hematological malignancies patients in Tianjin HI.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Institute of Hematology & Blood Diseases Hospital, China
NCT06597916 · RSV Infection
NCT05765396 · COVID-19, SARS-CoV-2 Virus, and more
NCT04938830 · RSV Infection
NCT07482657 · RSV Infection, RSV, and more
NCT03596801 · RSV Infection
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Tianjin
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions